transdermal glp-1 receptor agonist patch clinical trial Stimuli-responsive microneedle patches Mapping the effectiveness and risks
Description
However, by evaluating selective expansion opportunities alongside its primary GLP-1 development efforts, SureNano Science is positioning itself within a broader trend toward diversified therapeutic platforms capable of addressing multiple large and evolving healthcare markets
Yang, I.-T
L.BremserS.AlberJ.GiavaliscoP.et al (2020)
These drugs modulate dopaminergic signaling in the mesolimbic system, the brains reward circuit, which is also implicated in addiction
